"In premenopausal women, the ovaries are the largest source of estrogen," says Dr
Promising findings from clinical trials indicate that this medication may possess substantial potential for promoting weight loss
The SURMOUNT-5 trial, published in the New England Journal of Medicine in 2025, randomly assigned 751 adults with obesity to either tirzepatide or semaglutide for 72 weeks.[1] The results were clear: Average weight loss with tirzepatide: 20.2% Average weight loss with semaglutide: 13.7% Tirzepatide patients were also more likely to hit major milestones 10%, 15%, 20%, and even 25% body weight loss
If youve been hearing about Ozempic weight loss and Saxenda pens, youre not alone
Weight Loss Drug Profiles Profiles of every major weight loss drug we track
Most of these side effects of Carnisure 1 gm Injection 5 x 5 ml do not require medical attention and gradually resolve over time